Loading data
CAMTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 496.07 m USD | 429.23 m USD | 315.38 m USD | 320.91 m USD | 269.66 m USD |
| Cost of revenue | 245.76 m USD | 219.28 m USD | 167.74 m USD | 161.05 m USD | 132.32 m USD |
| Gross profit | 250.32 m USD | 209.95 m USD | 147.63 m USD | 159.86 m USD | 137.34 m USD |
| Research and development expense | 48.35 m USD | 38.29 m USD | 31.47 m USD | 28.86 m USD | 23.47 m USD |
| Selling, general and administrative expense | 73.77 m USD | 63.6 m USD | 50.75 m USD | 49.5 m USD | 42.97 m USD |
| Operating profit | 128.2 m USD | 108.07 m USD | 65.41 m USD | 81.5 m USD | 70.9 m USD |
| Profit before tax | 52.34 m USD | 131.24 m USD | 87.63 m USD | 88.19 m USD | 71.93 m USD |
| Income tax expense | 1.61 m USD | 12.72 m USD | 9 m USD | 8.24 m USD | 11.65 m USD |
| Net income (reported basis) | 50.72 m USD | 118.52 m USD | 78.63 m USD | 79.95 m USD | 60.28 m USD |
| Basic earnings per share | 1.11 USD/share | 2.62 USD/share | 1.76 USD/share | 1.81 USD/share | 1.38 USD/share |
| Diluted earnings per share | 1.04 USD/share | 2.42 USD/share | 1.63 USD/share | 1.68 USD/share | 1.34 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.